Market Overview:
The global Cerebral Angiography Market is estimated to be valued at US$14.96 billion in 2023, with a projected CAGR of 6.1% during the forecast period of 2023-2030, as revealed in a recent report by Coherent Market Insights. Cerebral angiography refers to a diagnostic procedure that uses X-ray imaging to visualize the blood vessels in the brain, helping in the diagnosis and treatment of various neurological conditions. This non-invasive procedure offers several advantages, including accurate visualization of blood flow, identification of flow abnormalities, and assessment of potential blockages or malformations. The rising prevalence of neurological disorders, coupled with technological advancements in diagnostic imaging, is driving the demand for cerebral angiography procedures worldwide.
Market Key Trends:
One key trend shaping the cerebral angiography market is the growing adoption of minimally invasive procedures. The shift towards minimally invasive techniques like digital subtraction angiography (DSA) and computed tomography angiography (CTA) is driven by their numerous advantages such as reduced post-operative complications, shorter hospital stays, and faster patient recovery. These techniques also offer real-time, high-resolution imaging, allowing for better visualization and diagnosis of vascular and neurovascular disorders. For instance, the use of 3D rotational angiography has revolutionized the diagnosis and treatment of complex brain aneurysms.
Porter's Analysis:
Threat of new entrants: The Cerebral Angiography Market Size has high entry barriers due to the need for significant capital investment in research and development, stringent regulatory requirements, and intellectual property rights. This factor limits the threat of new entrants in the market.
Bargaining power of buyers: As the number of players in the market is limited, buyers have less bargaining power. However, the market is highly competitive, which provides buyers with options to choose from various products and services based on their preferences.
Bargaining power of suppliers: Suppliers in the cerebral angiography market include medical device manufacturers and technology providers. The market has a large number of suppliers, giving them moderate bargaining power. However, technological advancements and quality requirements by regulators create opportunities for suppliers to differentiate their offerings.
Threat of new substitutes: While there are alternative diagnostic imaging techniques available for cerebral angiography, such as magnetic resonance angiography (MRA), CT angiography (CTA), and ultrasound, these techniques may not offer the same level of accuracy and visualization as cerebral angiography. Thus, the threat of substitutes remains relatively low.
Competitive rivalry: The cerebral angiography market is highly competitive, with key players investing in research and development activities to introduce innovative products and strengthen their market presence. The presence of major multinational companies has intensified the competition in the market.
Key Takeaways:
1. Market Size: The global cerebral angiography market is expected to witness high growth, exhibiting a CAGR of 6.1% over the forecast period. This growth is primarily attributed to the increasing prevalence of neurological disorders, advancements in diagnostic imaging technologies, and the shift towards minimally invasive procedures.
2. Regional Analysis: North America is anticipated to dominate the cerebral angiography market, driven by the presence of well-established healthcare infrastructure, favorable reimbursement policies, and high healthcare expenditure. Asia-Pacific is predicted to witness the fastest growth, attributed to the rising geriatric population and increased awareness regarding the diagnosis and treatment of neurological disorders.
3. Key Players: Key players operating in the global cerebral angiography market include Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Shimadzu Corporation, and Hitachi, Ltd. These companies focus on strategic collaborations, product launches, and investments in research and development to gain a competitive edge.
In conclusion, the cerebral angiography market is poised for significant growth in the coming years, driven by the increasing prevalence of neurological disorders and advancements in diagnostic imaging techniques. The adoption of minimally invasive procedures and the competitive landscape of key players further contribute to the market's expansion. As technology continues to evolve, there is immense potential for innovation and improved patient outcomes in the field of cerebral angiography.
Ischemic stroke market research report: by diagnosis (CT, MRI, carotid ultrasound, cerebral angiography), drug class (tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive), surgery, end user – Global forecast till 2023Market Scenario:Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain.
The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.
According to the World Health Organization (WHO), stroke accounts for around 17 million deaths annually.
As per the Centers for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around USD 34 billion each year in the U.S. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.Avail a Free Sample Insights @ https://www.marketresearchfuture.com/sample_request/5423 The global market for ischemic stroke is expected to grow at a CAGR of approximately 8.3% during the forecast period 2017-2023.Some of key the players in the Americas ischemic stroke market are Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.), Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and othersSegmentation:The ischemic stroke is segmented on the basis of diagnosis, drug class, surgery and end-users.On the basis of the diagnosis, the market is segmented into Computed Tomography (CT), Magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others.On the basis of the drug class, the market is segmented into tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and othersOn the basis of the surgery, the market is segmented into carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomyOn the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.Browse Complete Premium Research Report@ https://www.marketresearchfuture.com/reports/ischemic-stroke-market-5423 Intended Audience:Ischemic Stroke Drug SuppliersIschemic Stroke Drug ManufacturersResearch and Development (R) CompaniesMedical Research LaboratoriesAcademic Medical Institutes and UniversitiesAbout Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.Contact:Market Research Future +1 646 845 9312Email: [email protected]
According to IMARC Group’s latest report, titled “Stroke Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global stroke management market exhibited moderate growth during 2015-2020.
It relies on an echocardiogram, cerebral angiogram, carotid ultrasound, blood tests, magnetic resonance imaging (MRI), and computerized tomography (CT) scan and blood tests for a complete evaluation.
As per the assessment and patient’s condition, it assists physicians in opting for treatment options like endovascular procedures, intubation, intravenous (IV) medication, and surgeries.Request for a PDF sample of this report: https://www.imarcgroup.com/stroke-management-market/requestsamplePresently, there is a growing prevalence of chronic diseases, such as migraine, hypertension, diabetes, obesity, and cardiac diseases around the world.
Besides this, a significant rise in the geriatric population, which is relatively more vulnerable to stroke, is escalating catalyzing the demand for efficient stroke management worldwide.
This, along with increasing awareness about the benefits of early diagnosis and treatment, is driving the market.
Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026.As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.Competitive Landscape with Key Players:Abbott LaboratoriesBraun Melsungen AGBoston Scientific CorporationBristol-Myers Squibb CompanyCardinal HealthGeneral Electric CompanyGlaxoSmithKline plcMedtronic plcMerck & Co. Inc.Siemens Healthineers AG (Siemens AG).Market Segmentation:Breakup by Type:DiagnosticsComputed Tomography Scan (CT Scan)Magnetic Resonance Imaging (MRI)Carotid UltrasoundCerebral AngiographyElectrocardiographyEchocardiographyOthersTherapeuticsTissue Plasminogen ActivatorAnticoagulantAntiplateletAntihypertensiveBreakup by Application:Ischemic StrokeHaemorrhagic StrokeOthersBreakup by End User:HospitalsAmbulatory Surgical CentersDiagnostic CentersOthersBreakup by Region:North America (United States, Canada)Europe (Germany, France, United Kingdom, Italy, Spain, Others)Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)Latin America (Brazil, Mexico, Others)Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/stroke-management-marketWe are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc.
